GHK-Cu Dosing: How Much Copper Peptide to Use for Skin, Hair and Wound Healing
Most research protocols use topical concentrations between 0.05 % and 0.1 % or subcutaneous injections of 1–2 mg daily, but the ideal GHK-Cu dose depends on the route, goal and cycle length.
GHK-Cu (glycyl-L-histidyl-L-lysine-copper) is a naturally occurring copper-binding tripeptide that stimulates collagen production, modulates over 4,000 human genes and accelerates wound closure. Published studies most often use a 0.05-0.1 % cream twice daily or a 1–2 mg subcutaneous injection once daily for 4–8 weeks. Because the peptide is research-only and not FDA-approved, any dosing should be discussed with a qualified healthcare professional who can tailor the amount, route and cycle length to your skin status, medical history and healing goals.
- Most cosmetic studies used 0.05–0.1 % GHK-Cu cream twice daily for 8–12 weeks and reported significant improvements in firmness and elasticity.(pmc.ncbi.nlm.nih.gov)
- Animal wound models achieved faster closure with intramuscular injections delivering approximately 1 mg of GHK-Cu per day.(patents.google.com)
- The only active U.S. phase-2 trial applies a once-daily 0.05 % topical gel for 14 days on punch-biopsy wounds.(ichgcp.net)
What GHK-Cu Is and Why It Matters
GHK-Cu is a 340-dalton tripeptide naturally present in human plasma, saliva and urine that tightly binds copper(II) ions. Identified by Pickart in 1973, the complex signals skin fibroblasts to increase collagen, elastin and glycosaminoglycan synthesis, while down-regulating genes that drive inflammation and scar formation.(pubmed.ncbi.nlm.nih.gov) Topical and injectable forms are available from compounding pharmacies for investigational use and are popular in regenerative dermatology and aesthetic medicine.
How GHK-Cu Works in Skin and Wounds
The peptide acts as a copper shuttle, delivering the essential metal to enzymes such as lysyl oxidase that cross-link collagen, and to superoxide dismutase, a first-line antioxidant defense. In cultured human fibroblasts, GHK-Cu increased collagen synthesis by up to 70 % at 1 µM.(pubmed.ncbi.nlm.nih.gov) Animal studies show enhanced angiogenesis, faster re-epithelialization and stronger tensile strength of healed tissue.(patents.google.com)
Evidence-Based Dosing by Route
Most published data cluster around three delivery routes-topical, subcutaneous injection and microneedle-assisted transdermal dosing. The table below synthesizes peer-reviewed protocols.
| Route | Typical Concentration or Dose | Frequency | Cycle Length | Key Study |
|---|---|---|---|---|
| Topical cream/serum | 0.05–0.1 % w/w | BID | 8–12 weeks | Leyden et al., 2002(pmc.ncbi.nlm.nih.gov) |
| Topical post-procedure gel | 0.05 % | QD | 14 days | NCT07437586(ichgcp.net) |
| Subcutaneous injection | 1–2 mg | QD or 3×/week | 4–8 weeks | Pickart patent examples(patents.google.com) |
| Microneedle serum | 0.1 % (1 mg/mL) | Per procedure | Every 4 weeks × 3 | Miller 2006(pubmed.ncbi.nlm.nih.gov) |
Topical dosing: Twice-daily 0.05-0.1 % creams improved laxity and fine lines in women aged 50–59 within 12 weeks.(pmc.ncbi.nlm.nih.gov)
Subcutaneous dosing: Research veterinarians extrapolate rodent data to a human dose of 1 mg daily for small wounds and 2 mg for larger surgical sites, typically injected in the abdominal fat with an insulin syringe.
Microneedle or laser-assisted delivery: A 1927 nm fractional thulium laser followed by 0.1 % GHK-Cu serum accelerated re-epithelialization and reduced downtime compared with bland ointment.(pubmed.ncbi.nlm.nih.gov)
How to Reconstitute and Store GHK-Cu
GHK-Cu arrives as a lyophilized blue-green powder that must be reconstituted with bacteriostatic water before injection or microneedle use. See our detailed guide on bacteriostatic water for sterile technique.
| Vial Size | Diluent (mL) | Final Concentration (mg/mL) | Volume for 1 mg Dose | Max Fridge Life* |
|---|---|---|---|---|
| 50 mg | 5 mL | 10 mg/mL | 0.10 mL | 30 days at 2–8 °C |
| 50 mg | 10 mL | 5 mg/mL | 0.20 mL | 30 days at 2–8 °C |
| 100 mg | 10 mL | 10 mg/mL | 0.10 mL | 30 days at 2–8 °C |
*Stability data extrapolated from peptide pharmacy certificates of analysis; discard sooner if solution becomes cloudy or color shifts toward teal.
Is a 1 mg daily GHK-Cu injection right for you?
Check the column that fits your situation:
✅ Safe to proceed (with clinician oversight)
- Small surgical incision or microneedling planned
- Normal baseline copper and ceruloplasmin levels
- No history of Wilson’s disease or hemochromatosis
- Able to use sterile technique and refrigeration
🏥 See a clinician first
- Active infection or non-healing ulcer
- Known copper metabolism disorder
- Severe renal or hepatic impairment
- Pregnant or breastfeeding
- Taking high-dose zinc supplements (>40 mg/day)
Side Effects and Safety Data
Published human data report an excellent safety profile with only minor, transient events. In a randomized trial on CO2 laser-resurfaced skin, no severe adverse events occurred and patient satisfaction was higher in the peptide group.(pubmed.ncbi.nlm.nih.gov) Subcutaneous protocols describe occasional bruising, mild injection-site burning and temporary headaches, all resolving without intervention.
Copper overload is unlikely at research doses. A 2 mg daily dose supplies about 0.07 mg elemental copper, well below the 10 mg/day upper tolerable intake level set by the Institute of Medicine. Routine serum copper and ceruloplasmin checks every 4–6 weeks are still prudent.
Combining GHK-Cu With Other Therapies
Procedure synergy: Laser resurfacing, radiofrequency microneedling and chemical peels create micro-channels that enhance peptide penetration and may justify shortening cycles to 4 weeks.
Stacking with other peptides: Some clinicians pair GHK-Cu with TB-500 for tendon injuries or with K-LOW peptide for additional anti-inflammatory support, though formal studies are limited.
Adjunct nutraceuticals: Vitamin C (500 mg twice daily) supplies ascorbate needed by pro-collagen hydroxylase, while amino acid sufficiency (especially lysine and proline) supports new collagen matrix formation.
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Sudden swelling or warmth at the injection site - could signal infection or sterile abscess.
- Persistent nausea or abdominal pain - possible copper overload affecting the liver.
- Yellowing of the skin or eyes - sign of hepatotoxicity.
- Unexplained fatigue or anemia - excess copper can induce hemolysis.
- Neurological symptoms such as tremor or difficulty walking.
- Bluish discoloration of lips or nails - rare copper-induced methemoglobinemia.
- Severe rash or hives after topical application.
- Any worsening of a chronic wound despite peptide use.
Scientific References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018.
- Maquart FX et al. Stimulation of Collagen Synthesis in Fibroblast Cultures by the Tripeptide-Copper Complex GHK-Cu. J Invest Dermatol. 1988.
- Pickart L. Method of Using Copper(II) Containing Compounds to Accelerate Wound Healing. US Patent 5,164,367. 1992.
- Miller TR et al. Effects of Topical Copper Tripeptide Complex on CO2 Laser-Resurfaced Skin. Arch Facial Plast Surg. 2006.
- Pickart L et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioFactors. 2015.
- ClinicalTrials.gov Identifier NCT07437586. Topical GHK-Cu Gel for Acute Skin Wound Healing. Updated 2026.
Frequently Asked Questions
Is GHK-Cu FDA-approved?
No. GHK-Cu is considered a research peptide and is not approved by the U.S. Food and Drug Administration for any indication. Any clinical use is off-label and should be supervised by a licensed provider.
Can I apply GHK-Cu every day forever?
Most studies run 8–12-week courses followed by a 4-week break to assess results. Continuous long-term topical use has not been formally studied, so periodic cycling is prudent.
Does copper in multivitamins interfere with dosing?
A standard multivitamin contains 0.9 mg copper, which is well below the tolerable intake level and unlikely to cause interactions with a 1–2 mg peptide dose.
How soon will I see results on fine lines?
Subjects in cosmetic trials noticed improved firmness as early as week 4, with statistically significant wrinkle depth reduction by week 8. Individual response varies.
Can I mix GHK-Cu with retinoids?
Yes, but introduce slowly. Apply retinoid at night and GHK-Cu in the morning to minimize irritation, and monitor for dryness or peeling.
Is there a hair-growth dose?
Small pilot studies use a 0.1 % spray (1 mg/mL) applied nightly to the scalp for 12 weeks, reporting increased anagen to telogen ratios. Larger randomized trials are still needed.
What is the best needle depth if I microneedle GHK-Cu?
Dermatologists often use 0.5 mm on the face and 1.0 mm on the scalp to create micro-channels without inducing deep bleeding. GHK-Cu is applied immediately post-rolling.